A case report of severe veno-occlusive disease following autologous stem cell transplantation successfully treated with Defibrotide
Veno-occlusive disease (VOD) is one of the complications of hematopoietic stem cell transplantation that can also be caused by high-dose chemotherapy. This complication can lead to high mortality following bone marrow transplantation. It is more common after allogeneic stem cell transplantation, and...
Main Authors: | Gholamreza Bahoush, Maryam Vafapour |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2020-09-01
|
Series: | European Journal of Translational Myology |
Subjects: | |
Online Access: | https://www.pagepressjournals.org/index.php/bam/article/view/9161 |
Similar Items
-
Defibrotide in the treatment of hepatic veno-occlusive disease
by: Fulgenzi A, et al.
Published: (2016-10-01) -
Risk factors analysis and defibrotide efficacy in the treatment of children and adults with sinusoidal obstructive syndrome/veno-occlusive liver disease after allogeneic hematopoietic stem cell transplantation
by: M. M. Kanunnikov, et al.
Published: (2021-06-01) -
Interest of the preventive and curative use of defibrotide on the occurrence and severity of sinusoidal obstruction syndrome after hematopoietic stem cell transplant in children
by: Carl J. Rudebeck, et al.
Published: (2022-08-01) -
Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation
by: Takashi Hamada, et al.
Published: (2023-05-01) -
Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide
by: Julia Martinez-Sanchez, et al.
Published: (2019-10-01)